reports
Form 8.3 - Balanced Commercial Property Trust Limited
Form 8.3 - Balanced Commercial Property Trust Limited 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant se...
Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Tim...
Staffing 360 Solutions Receives Nasdaq Notification Related to Non-Timely Filing of its 2023 Form 10-K NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- () (“Staffing 360” or the “Company”), a company executing a buy-integrate-build strategy through the acquisition of staffing organizations in the United States, today reported that it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of not havin...
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Dema...
Enhanced Inventory Management Solutions to Meet Rising E-Commerce Demand TULSA, Okla., April 23, 2024 (GLOBE NEWSWIRE) -- Ladybug Resource Group, Inc. (OTC PINK: LBRG), operating as Ladybug NutraTech, is delighted to announce the expansion of its logistical capabilities with the opening of a second warehouse by Fitness Fuel Depot Ltd. (herein referred to as “FFD”) This new facility, located in the greater Toronto area, is specifically designed to accommodate the growing inventory requirements of Ladybug’s e-commerce platforms. This strategic expansion aims to enhance our distribution effi...
Form 8.3 - ABRDN European Logistics Income Plc
Form 8.3 - ABRDN European Logistics Income Plc 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Rathbones Group Plc(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securitie...
Xometry to Announce First Quarter 2024 Financial Results on May 9, 202...
Xometry to Announce First Quarter 2024 Financial Results on May 9, 2024 NORTH BETHESDA, Md., April 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: XMTR), the global AI-powered tech marketplace connecting enterprise buyers with suppliers of manufacturing services, today announced it will report its first quarter 2024 financial results before the market opens on May 9, 2024. Xometry will host its conference call and webcast to discuss the results at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). In addition to its press release announcing its first quarter 2024 financial results, Xometry will r...
Old National Bancorp Reports First Quarter 2024 Results
Old National Bancorp Reports First Quarter 2024 Results EVANSVILLE, Ind., April 23, 2024 (GLOBE NEWSWIRE) -- Old National Bancorp (NASDAQ: ONB) reports 1Q24 net income applicable to common shares of $116.3 million, diluted EPS of $0.40; $130.8 million and $0.45 on an adjusted1 basis, respectively. CEO COMMENTARY: "Old National's positive quarterly results were highlighted by continued growth in our granular, peer-leading deposit franchise, disciplined loan growth, a year-over-year tangible book value increase, and stable credit quality," said Chairman and CEO Jim Ryan. "We a...
Baker Hughes Awarded Significant Gas Technology Scope for Phase 3 of S...
Baker Hughes Awarded Significant Gas Technology Scope for Phase 3 of Saudi Arabia’s Master Gas System Baker Hughes to supply 17 pipeline centrifugal compressors driven by state-of-the-art aeroderivative gas turbinesAward builds on Master Gas System Phase 1 & 2 agreement, which saw Baker Hughes deliver 18 centrifugal compressors driven by aeroderivative gas turbinesNew pipeline aims to increase gas distribution across Saudi Arabia, supporting the Kingdom’s ambition to reduce carbon emissions HOUSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy tec...
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polyme...
TMC & SGS Produce World-First Nickel Sulfate from Deep-Seafloor Polymetallic Nodules As part of TMC’s pilot-scale nodule processing, SGS and TMC produced the world's first nickel sulfate from deep-seafloor polymetallic nodules, indicating TMC’s resource is suitable for battery marketsThe nickel sulfate was produced in a testing program conducted in collaboration with SGS and other industry leaders applying TMC’s efficient flowsheet design that processes high-grade nickel matte direct to nickel sulfate (without making nickel metal) and produces fertilizer products instead of solid waste or t...
Preferred Bank Reports Quarterly Results
Preferred Bank Reports Quarterly Results LOS ANGELES, April 23, 2024 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent California banks, today reported results for the quarter ended March 31, 2024. Preferred Bank (“the Bank”) reported net income of $33.5 million or $2.44 per diluted share for the first quarter of 2024. This represents a decrease in net income of $2.4 million or 6.6% from the prior quarter and down by $4.6 million from the same quarter last year. Despite the decrease in net income, Preferred Bank continues to deliver top-of-class profitabili...
Altus Group Announces Winners of the 2024 ARGUS University Challenge
Altus Group Announces Winners of the 2024 ARGUS University Challenge University of San Diego real estate team presented the top investment opportunity & claims first place TORONTO, April 23, 2024 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group” or “the Company”) (TSX: AIF), a leading provider of asset and fund intelligence for commercial real estate (“CRE”), is pleased to announce the 2024 winners of its 15th annual ARGUS University Challenge. Teams of aspiring real estate professionals from leading universities across the world competed for scholarship awards by identifying the t...
Parex Resources Announces Timing of Q1 2024 Results, Annual General Me...
Parex Resources Announces Timing of Q1 2024 Results, Annual General Meeting, and Foothills Investor Presentation CALGARY, Alberta, April 23, 2024 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce that it plans to release its Q1 2024 financial and operating results on Wednesday, May 8, 2024, hold its Annual General and Special Meeting of Shareholders on Thursday, May 9, 2024, and host an investor presentation providing an overview of the Llanos Foothills Trend on Tuesday, April 23, 2024. Q1 2024 Results – Conference Call & Video Webcast ...
Solid Power, Inc. Announces Timing of First Quarter 2024 Earnings Rele...
Solid Power, Inc. Announces Timing of First Quarter 2024 Earnings Release and Conference Call LOUISVILLE, Colo., April 23, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SLDP), a developer of solid-state battery technology, today announced that it will release its first quarter 2024 results after market close on Tuesday, May 7, 2024, to be followed by a conference call at 2:30 p.m. MT (4:30 p.m. ET) on the same day. Interested investors and other parties can listen to a webcast of the live conference call through Solid Power’s Investor Relations website at . The conference call can also be accessed...
The Oncology Institute Announces First Quarter 2024 Earnings Release D...
The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-...
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatmen...
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) Abstract selected as a “Top Poster”, ranking it among the 1-2% of top-rated abstracts in the category submitted and accepted at ECCMID 2024 CAMBRIDGE, Mass. and NESS ZIONA, Israel, April 23, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that targ...
Daré Bioscience Announces Grant Funding Installment to Support Further...
Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1 Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases Strategic Process Underway to Explore Partnering Opportunities for Additional Indications such as with GLP-1s for Obesity and Metabolic Disorders and Other Conditions Requiring Precise, Prolonged Treatment SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health i...
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric ...
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapies for serious metabolic and rare diseases, today announced that a poster titled “An Analysis of Overnight Hypoglycemia in Patients with Congenital Hyperinsulinism: Results from the RZ358-606 (RIZE) Study” will be presented at the Pediatric Endocrine Society (PES) Annual Meetin...
Provident Bank Donates Original Bank Ledgers Dating Back to 1839 to th...
Provident Bank Donates Original Bank Ledgers Dating Back to 1839 to the Jersey City Free Public Library ISELIN, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, proudly announces the donation of its original bank ledgers to the Jersey City Free Public Library. These ledgers, which date back to the early days of Provident Bank, represent a significant piece of the city's financial history. Provident Bank was established in 1839 in a one-room office in Jersey City, and it holds the distinction of being the oldest New Jersey-based ba...
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc....
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market The pharmaceutical subsidiary plans on capturing a large portion of a growing market with an innovative prescription method. SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- (OTCQB: , “Dalrada,” “the Company”), announced today that its wholly-owned healthcare subsidiary, (“Genefic”), has added a telemedicine service to its , allowing Genefic to efficiently offer clients direct access to its pharmaceuticals, including access to Genefic’s own wei...
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical St...
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME SOUTH SAN FRANCISCO, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that the ongoing Phase 2b ASPIRE study of UBX1325 has been extended from 24 to 36 weeks to assess potentially greater durability compared to aflibercept. In addition, the study is being upsized from 40 to 50 patients to increase the statistical power. The ASPIRE study is ...
Luckin Coffee to Announce First Quarter 2024 Financial Results on Apri...
Luckin Coffee to Announce First Quarter 2024 Financial Results on April 30, 2024 BEIJING, April 23, 2024 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its first quarter 2024 financial results before the U.S. market open on Tuesday, April 30, 2024. The Company will hold a conference call on Tuesday, April 30, 2024 at 8:00 am Eastern Time (or Tuesday, April 30, 2024 at 8:00 pm Beijing Time) to discuss the financial results. Participants may access the call by dialing the following numbers: United States Toll Free: Internation...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.